Literature DB >> 12145909

[Dosimetric verification of IMRT treatment plans at the German Cancer Research Center (DKFZ)].

Bernhard Rhein1, Peter Häring, Jürgen Debus, Wolfgang Schlegel.   

Abstract

The present paper describes a method for the individual dosimetric verification of IMRT treatment plans. The German Cancer Research Center (Deutsches Krebsforschungszentrum; DKFZ) has implemented the intensity modulated radiotherapy (IMRT) since 1997. So far, 246 patients with head and neck cancer, cancer of the prostate, breast, and vertebral column, as well as mesothelioma of the pleura have been treated. Every IMRT plan is transferred into a special IMRT verification phantom, recalculated, and dosimetrically verified. Absolute dose distributions are measured with Kodak EDR films and compared with the results of the dose calculation. After correction of the optical density in relationship to the dose, EDR films are able to measure the absolute dose with an accuracy of +/- 2% compared to an ionization chamber. A visual C++ software tool has been developed to correlate and evaluate the film dose distributions with the corresponding slices of the 3D dose cube. Beside the overlay of absolute or relative isodoses and dose profiles, the median dose within correlated regions of interest (ROIs) is also included in the quantitative dose evaluation. The deviation between EDR film dosimetry and dose calculation is delta D = -0.3% +/- 2.3%. After introduction of the verification software, the total verification time (including handling, correlation, evaluation, and documentation of the data), could be reduced to less than 2 hours.

Entities:  

Mesh:

Year:  2002        PMID: 12145909     DOI: 10.1016/s0939-3889(15)70455-1

Source DB:  PubMed          Journal:  Z Med Phys        ISSN: 0939-3889            Impact factor:   4.820


  6 in total

Review 1.  [Optimizing the use of radiotherapy with IMRT and image guided location of advanced prostate cancer].

Authors:  F Lohr; M Fuss; U Tiefenbacher; M Siegsmund; S Mai; J M Kunnappallil; B Dobler; P Alken; F Wenz
Journal:  Urologe A       Date:  2004-01       Impact factor: 0.639

2.  [Intensity modulated radiotherapy (IMRT) of head and neck tumors. Increased biological effectiveness in high-risk situations by "integrated boost" therapy].

Authors:  D Milanovic; F Lohr; K Götte; B Dobler; B Hermann; K Hörmann; F Wenz
Journal:  HNO       Date:  2004-08       Impact factor: 1.284

3.  Clinical implementation of volumetric intensity-modulated arc therapy (VMAT) with ERGO++.

Authors:  Dirk Wolff; Florian Stieler; Brigitte Hermann; Katharina Heim; Sven Clausen; Jens Fleckenstein; Martin Polednik; Volker Steil; Frederik Wenz; Frank Lohr
Journal:  Strahlenther Onkol       Date:  2010-04-26       Impact factor: 3.621

4.  Curcumin decreases survival of Hep3B liver and MCF-7 breast cancer cells: the role of HIF.

Authors:  Mareike Ströfer; Wolfgang Jelkmann; Reinhard Depping
Journal:  Strahlenther Onkol       Date:  2011-06-27       Impact factor: 3.621

Review 5.  Intensity modulated radiotherapy (IMRT) in the treatment of children and adolescents--a single institution's experience and a review of the literature.

Authors:  Florian Sterzing; Eva M Stoiber; Simeon Nill; Harald Bauer; Peter Huber; Jürgen Debus; Marc W Münter
Journal:  Radiat Oncol       Date:  2009-09-23       Impact factor: 3.481

6.  IMRT-application with an add-on MMLC.

Authors:  Thomas Tücking; Simeon Nill; Uwe Oelfke
Journal:  J Appl Clin Med Phys       Date:  2003       Impact factor: 2.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.